Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15211037 | 0.98 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL7010601 | 0.95 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL27660311 | 0.80 | ALDH1A1 (0.41) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| Sulfuric Acid Diethyl Ester SCHEMBL25193310 | 0.77 | CA1 (0.43) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL29242383 | 0.76 | CA1 (0.39) | ALDH1A1CA1CA2 | |
| SCHEMBL114520 | 0.76 | ALDH1A1 (0.41) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL1252810 | 0.76 | THRB (0.42) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL27260870 | 0.76 | ALDH1A1 (0.41) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL25504746 | 0.74 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL1943125 | 0.74 | THRB (0.41) | ALDH1A1LMNAHSD17B10CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107430341-A | Photosensitive polymer combination, the manufacture method of resin film, the manufacture method of organic semiconductor device and fluoropolymer | 旭硝子株式会社 | 2017-12-01 | — | — | CN | disclosed |
| CN-107311935-A | For synthesizing and using the composition of contrast agent, method and system | 蓝瑟斯医学影像公司 | 2017-11-03 | — | — | CN | disclosed |
| CN-104803891-B | Glucagon antagonist | 症变治疗公司 | 2017-10-20 | — | — | CN | disclosed |
| CN-105504232-B | The new method of copolymer is prepared based on two kinds of different carbon radicals co-coupling reactions | 浙江大学 | 2017-07-18 | — | — | CN | disclosed |
| CN-105461904-B | A kind of new method that polymer is prepared based on carbon radicals coupling reaction | 浙江大学 | 2017-06-20 | — | — | CN | disclosed |
| CN-105452913-A | Optical film, and polarizing plate and liquid crystal display device that use this optical film | FUJIFILM CORP | 2016-03-30 | — | — | CN | disclosed |
| CN-105384723-A | Liquid crystal compound, liquid crystal composition, polymer and application | JNC PETROCHEMICAL CORP | 2016-03-09 | — | — | CN | disclosed |
| CN-102171216-B | Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optically anisotropic body | ZEON CORP | 2014-07-23 | — | — | CN | disclosed |
| CN-102341380-A | Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use | NEUROTHERAPEUTICS PHARMA INC | 2012-02-01 | — | — | CN | disclosed |
| CN-1642929-B | Kappa-opioid receptor agonists containing 2-phenylbenzothiazoline derivatives | SANTEN PHARMACEUTICAL CO LTD | 2010-05-12 | — | — | CN | disclosed |
| US-5268387-A | Containing ester or carbamate group | ALLERGAN, INC. (US) | 1993-12-07 | — | — | US | disclosed |
| WO-1993021915-A1 | PHARMACEUTICAL COMPOSITIONS FOR INHIBITING BONE LOSS CONTAINING 3 AND 4-SUBSTITUTED 2(5H)-FURANONES | ALLERGAN, INC. (US) | 1993-11-11 | — | — | WO | disclosed |
| EP-0524979-A4 | 2(5H)-FURANONES SUBSTITUTED IN THE 5 AND OR IN THE 4 POSITION, AS ANTI-INFLAMMATORY AGENTS | — | 1993-03-10 | — | — | EP | disclosed |
| EP-0524979-A1 | 2(5H)-FURANONES SUBSTITUTED IN THE 5 AND OR IN THE 4 POSITION, AS ANTI-INFLAMMATORY AGENTS | ALLERGAN, INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1991016055-A1 | 2(5H)-FURANONES SUBSTITUTED IN THE 5 AND OR IN THE 4 POSITION, AS ANTI-INFLAMMATORY AGENTS | ALLERGAN, INC. (US) | 1991-10-31 | — | — | WO | disclosed |
| CN-1051731-A | Herbicidal compound, its preparation method and methods for using them | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1991-05-29 | — | — | CN | disclosed |
| EP-0014057-B1 | GUANIDINE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-01-02 | — | — | EP | disclosed |
| US-4342765-A | Guanidine derivatives and pharmaceutical compositions containing them | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-08-03 | — | — | US | disclosed |
| US-4278670-A | TREATING BACTERIAL INFECTIONS | SMITHKLINE CORPORATION (US) | 1981-07-14 | — | — | US | disclosed |
| EP-0014057-A1 | Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1980-08-06 | — | — | EP | disclosed |